Junk DNA: how the dark genome is changing RNA therapies

Megatrend Biotech: Dieser Investor kennt fünf Startups mit blendenden Aussichten

The Longevity Biotechnology Association (LBA): Defining a Longevity Biotechnology Company

Samsara Therapeutics adds eminent neurologist Professor Dame Pamela Shaw to its scientific advisory board to help accelerate ALS/MND treatment development

Samsara Therapeutics Parkinson’s drug receives funding boost from The Michael J. Fox Foundation

Samsara Therapeutics unveils promising autophagy drug candidate, offering new hope for people with Parkinson’s and motor neurone disease

Cleara Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development

Paul Scherrer Institute and Apollo Health Ventures Launch Focal Biosciences